With 0.21 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.15 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $4.915 whereas the lowest price it dropped to was $4.5764. The 52-week range on CPIX shows that it touched its highest point at $7.25 and its lowest point at $1.85 during that stretch. It currently has a 1-year price target of $9.75. Beta for the stock currently stands at -0.52.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CPIX was down-trending over the past week, with a drop of -6.06%, but this was up by 30.25% over a month. Three-month performance surged to 34.78% while six-month performance rose 44.41%. The stock gained 16.83% in the past year, while it has gained 69.71% so far this year.
Float and Shares Shorts:
At present, 14.96 million CPIX shares are outstanding with a float of 8.73 million shares on hand for trading. On 2025-12-31, short shares totaled 0.14 million, which was 94.0 higher than short shares on 1764288000. In addition to Mr. A. J. Kazimi MBA as the firm’s Founder, Chairman, President & CEO, Mr. John Michael Hamm C.M.A. serves as its VP & CFO.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-09-30, CPIX reported revenue of $8292362.0 and operating income of -$1965260.0. The EBITDA in the recently reported quarter was -$510689.0 and diluted EPS was -$0.13.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. The surprise factor in the prior quarter was -$0.07.
